Physician profile
Barbara K Chen
NPI 1831309897
$6,318.43
in general payments reported to CMS, 2019-2025
43 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $537 · 2021: $636 · 2022: $896 · 2023: $298 · 2024: $1,659 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,600 · Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,600.00 |
| Food and Beverage | $836.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,618.01 | 2024-2025 | Bovine Collagen |
| Novo Nordisk INC | $901.42 | 2019-2025 | Wegovy, Saxenda |
| Abbvie INC. | $521.50 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $310.11 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $219.29 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $181.30 | 2022 | |
| Millicent US INC | $179.91 | 2020-2024 | Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $166.55 | 2019-2023 | |
| Genentech USA, INC. | $120.75 | 2022 | |
| Exeltis, USA INC. | $103.93 | 2019-2022 | |
| Janssen Biotech, INC. | $103.85 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $82.38 | 2019 | |
| Therapeuticsmd, INC. | $62.96 | 2019-2021 | |
| Dexcom, INC. | $61.94 | 2025 | Dexcom G6 Transmitter |
| Organon LLC | $59.81 | 2023-2024 | Jada System |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.